Coherus Oncology Congress Trades
NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Jan 23, 2023
Coherus Oncology Congress trading summary
Members of Congress have disclosed 1 transaction in Coherus Oncology (CHRS) stock, reported by 1 politician. No CHRS trades were reported with a transaction date in the past 12 months. The most active trader is Rep. Shri Thanedar (1).
The latest reported trade is a sale by Shri Thanedar dated Jan 23, 2023 and disclosed on Feb 9, 2023. The most common reported amount is $15,001 – $50,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading CHRS
CHRS trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Shri ThanedarD-MIHouse | Sell | $15,001 – $50,000 | Jan 23, 2023 | Filing for Shri Thanedar CHRS trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell CHRS. How Congress trading data works